Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
Complete Title: A phase I study assessing the safety and tolerability of ascending doses of AZD1390 in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic solid tumor malignancies
Trial Phase: I
Investigator: Jonathan Yang
The purpose of this study is to find out whether AZD1390 combined with stereotactic body radiation therapy/SBRT is a safe treatment for people with metastatic solid tumor cancer
Keywords:
- Solid Tumors
- Metastatic Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
I
Jonathan Yang
RG1123039
NCT05678010
A phase I study assessing the safety and tolerability of ascending doses of AZD1390 in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic solid tumor malignancies
Solid Tumors
Metastatic Solid Tumors